Dimethyl fumarate in multiple sclerosis: latest developments, evidence and place in therapy
Dimethyl fumarate in multiple sclerosis: latest developments, evidence and place in therapy
About this item
Full title
Author / Creator
Publisher
London, England: SAGE Publications
Journal title
Language
English
Formats
Publication information
Publisher
London, England: SAGE Publications
Subjects
More information
Scope and Contents
Contents
Dimethyl fumarate (DMF) is one of the newer additions to the armamentarium of potent immunomodulators for the treatment of relapsing-remitting multiple sclerosis (RRMS). After more than 2 years of real-world experience and more than 190,000 patients currently treated with DMF worldwide, it is a good timepoint to review the experience gathered so fa...
Alternative Titles
Full title
Dimethyl fumarate in multiple sclerosis: latest developments, evidence and place in therapy
Authors, Artists and Contributors
Author / Creator
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_4935836
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_4935836
Other Identifiers
ISSN
2040-6223
E-ISSN
2040-6231
DOI
10.1177/2040622316653307
